Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
“I don't think OTC scams are usually profitable or debt free.”
No, but they often pretend they are.
And OTC scams always blame short sellers for pps weakness when invariably the real cause is insider selling and the absence of a real business model beyond fleecing their hapless marks.
Truer than ever:
When penny stock CEO self-enrichment schemes like IPIX fall below 2 cents and begin their inevitable (although often punctuated by brief spikes) decline to the trips, it becomes clearer who among their followers are sheep who have been woefully misled and misdirected by the said CEO, and who are the wolves in sheep's clothing who have actively connived with the CEO to transfer his marks' money to their own pockets while pretending to be among those very marks.
While I already have a pretty good idea who on social media (not iHUb, obvs!) falls into each camp, it will be fascinating to get a more forensic feel for this over the coming months.
No, it isn’t.
Got it. Emil doesn't need the money.
It must be the second explanation, then:
One day the ump will yell "strike out!" for this scam of a company, and for its fifth rate boosters on social media.
“My bet is the reason for the reverse split is to get rid of that sociopathetic asshole...”
With quotation marks this time so that no one thinks I’m the illiterate idiot who wrote this.
“It is an inconvenient truth williamssc”
If it were true, it would be inconvenient.
However it’s 100% false, as has been documented here on every occasion this profound misconception has been regurgitated.
“Whats never noted is that all patience in the ABSSSI trial went home cured.”
That’s total bullshit, of course.
Brilacidin was statistically equal to daptomycin in terms of efficacy, which in reality was nowhere near 100% for either treatment.
But caused roughly twice as many side effects in twice as many people, as my previous posts documents.
Here’s the evidence, yet again:
It should be very clear that even the minimum dose of brilacidin resulted in 79.2% of patients experiencing at least one adverse event.
In fact on average that 79.2% experienced more than two adverse events each on average.
The arms with higher doses were much worse.
On average patients on brilacidin experienced more than twice as many adverse events as those on daptomycin.
The raw data shows six brilacidin patients suffered serious adverse events as opposed to none on daptomycin. The odds that this is due to random chance are trivially small.
I’d like this entered into the record so that the false claim that brilacidin does not cause side effects in upwards of 70% of patients (in fact it’s nearly 80%) can not be trotted out any longer.
“Brilacidin + BeaMed = CASH”
True. Shareholders’ cash being given to Leo’s Israeli BeaMed buddies.
I wonder how much of that $4 million Leo gets to place in his own bank account?
Of course, the real kiss of doom will be if the world's least successful stock pimp, Hans Brost, should take an interest in OODH.
If that pitiful excuse for a promoter gets involved, it isn't just the goats that will be receiving -ahem- unwanted attention.
And receiving it good and hard.
“Do BPs have some sort of input with the major hospitals where some worker can slew the results as that would be quite cost effective for BPs”
No. Just another ludicrous conspiracy theory.
The truth is IPIX is a failed company with a greedy grifting liar for a CEO.
I should.
OTOH I should point out that I think the FDA does a pretty good job in difficult circumstances.
Pure conspiracy theory fantasy bullshit.
The hard truth is that Kevetrin, Prurisol and Brilacidin either don't work (K and P), have terrible side effects, or both (B).
The responsibility for performing clinical trials rests solely with the CEO of this sorry mess, and he'd rather give his shareholders' funds to his Israeli buddies than spend it developing his own drugs.
That tells you all you need to know.
The fda had got to change the process to approval.. we are stuck in mid evil times
“a 2-person trial showing trial showing efficacy”
is a contradiction in terms.
“A quick in vitro followed by a small in vivo study might suffice given our well established safety profile.”
It’s precisely the fact that it’s well established that brilacidin causes peripheral neuropathy and hypertension in upwards of 70% of those unlucky enough to be administered it, even topically as in OM, that means it could never be considered to have an appropriate risk/benefit ratio in prophylaxis or - as you suggest- as a preservative or sterilising agent in eye drops.
In fact even in any but the most serious of infections, even if it worked in humans - and so far the evidence is mixed - the risk/benefit ratio is unlikely to be in its favor.
Looks like Hans Brost and the other pimps touting this hopeless scam have worked their usual magic.
I really wonder why anyone hires Hans and his cohorts to work social media any more.
His presence is like the kiss of death.
“If the reverse merger happens”
It won’t.
“it looks like Leo will have to surrender his majority”
What majority?
“new bacterial infection called Shigella”
Shigella is hardly new. It’s been known about since 1896:
“Shigella dysentariae, was named after Kiyoshi Shiga, a Japanese scientist who discovered it in 1896 while investigating a large epidemic of dysentery in Japan. The genus was first termed Shigella in the 1930 edition of Bergey's Manual of Determinative Bacteriology.”
https://about-shigella.com/
“A successful 510k could result in our shares appreciating substantially."
If the technology is as unique and first-in-class as claimed, then the 510k route will not be available for the BeaMed product.
“pleased to announce that it intends to complete a non-brokered private placement financing”
And I’m pleased to announce that I intend to complete my long-awaited novel later this month.
One of these is much more probable than the other (my novel), but in reality neither will come to pass.
“In spite of the success of his therapy, he has faced the prosecution of big pharma and the FDA which has tried to stop his therapy from spreading in the United States.”
His “therapy” never worked, except to make him a multi millionaire.
Stanislaw Burzynski belongs in Hell. I hope he gets there soon.
“I wonder what the founders of BeaMed would think about that scenario? That they're in bed with a crook”
Maybe they’d think “we’re lucky that we’ve found someone with a similar outlook with whom we can do business”.
No rational person sells an asset for 1% or even 10% of its real value.
The conclusion is obvious. Mrs Malak doesn’t think a VPLM share is worth 50 cents, let alone some of the ludicrous figures that have been touted.
Mind you she probably knows more about the patents than most.
“so Emil's wife is one of his marks? Having trouble following this”
Obviously.
No, she would be one of his - and Inza’s - marks if she’d followed the advice of their social media minions and increased her holding.
Instead she very sensibly is planning to dump or already has dumped over $260,000 worth of stock.
Clearly she doesn’t have the same faith in the patents that Emil and Rich urge their marks to have.
I do hope that’s clearer.
“The reason is that Emil and Rich want their marks to buy and hold while they and their cohorts sell their free shares into any volume their social media minions can generate.”
How prescient of me.
The only surprise is that someone filed a form 144 on her behalf.
I wonder why they were so meticulous on this occasion?